EU/US Properties Organoleptics Cosmetics Suppliers Safety Safety in use Safety references References Other Blenders Uses Occurrence Synonyms Articles Notes
 

choline dihydrogen citrate
2-hydroxy-N,N,N-trimethylethanaminium salt with 2-Hydroxy-1,2,3-propanetricarboxylic acid (1:1)

Supplier Sponsors

Name:2-(carboxymethyl)-2,4-dihydroxy-4-oxobutanoate;2-hydroxyethyl(trimethyl)azanium
CAS Number: 77-91-8Picture of molecule3D/inchi
Other(deleted CASRN):147584-41-6
ECHA EINECS - REACH Pre-Reg:201-068-6
FDA UNII: DQ8HHP07GL
MDL:MFCD00038734
Molecular Weight:295.28897000
Formula:C11 H21 N O8
NMR Predictor:Predict (works with chrome, Edge or firefox)
Category:pharmaceuticals / chemical synthisis
 
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Google Scholar:Search
Google Books:Search
Google Scholar: with word "volatile"Search
Google Scholar: with word "flavor"Search
Google Scholar: with word "odor"Search
Google Patents:Search
US Patents:Search
EU Patents:Search
Pubchem Patents:Search
PubMed:Search
NCBI:Search
 
Physical Properties:
Assay: 95.00 to 100.00
Food Chemicals Codex Listed: No
Melting Point: 106.00 °C. @ 760.00 mm Hg
Boiling Point: 309.60 °C. @ 760.00 mm Hg (est)
Vapor Pressure:0.000057 mmHg @ 25.00 °C. (est)
Flash Point: 311.00 °F. TCC ( 155.20 °C. ) (est)
logP (o/w): -1.721 (est)
Soluble in:
 water, 1e+006 mg/L @ 25 °C (est)
 
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found).
 
Cosmetic Information:
None found
 
Suppliers:
American International Chemical, LLC.
Choline Citrate
BOC Sciences
For experimental / research use only.
Choline Dihydrogen Citrate > 95%
Odor: characteristic
Use: Choline Dihydrogen Citrate is a highly effective nutritional supplement agents. It can promote fat metabolism and prevent fat accumulation in the liver .
Charkit Chemical
CHOLINE DIHYDROGEN CITRATE
Indis NV
For experimental / research use only.
Choline Dihydrogen Citrate
Penta International
CHOLINE DIHYDROGEN CITRATE
Sigma-Aldrich: Aldrich
For experimental / research use only.
Choline dihydrogencitrate salt ≥98%
sds
TCI AMERICA
For experimental / research use only.
Choline Dihydrogen Citrate >99.0%(T)
sds
 
Safety Information:
Preferred SDS: View
 
Hazards identification
 
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
 
Pictogram
 
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
intraperitoneal-mouse LD50 > 4800 mg/kg
Drugs in Japan Vol. 6, Pg. 563, 1982.

intravenous-mouse LD50 > 4800 mg/kg
Drugs in Japan Vol. 6, Pg. 563, 1982.

oral-mouse LD50 > 4800 mg/kg
Drugs in Japan Vol. 6, Pg. 563, 1982.

intraperitoneal-rat LD50 > 4800 mg/kg
Drugs in Japan Vol. 6, Pg. 563, 1982.

intravenous-rat LD50 > 4800 mg/kg
Drugs in Japan Vol. 6, Pg. 563, 1982.

oral-rat LD50 > 4800 mg/kg
Drugs in Japan Vol. 6, Pg. 563, 1982.

Dermal Toxicity:
subcutaneous-mouse LD50 > 4800 mg/kg
Drugs in Japan Vol. 6, Pg. 563, 1982.

subcutaneous-rat LD50 > 4800 mg/kg
Drugs in Japan Vol. 6, Pg. 563, 1982.

Inhalation Toxicity:
Not determined
 
Safety in Use Information:
Category:
pharmaceuticals / chemical synthisis
Recommendation for choline dihydrogen citrate usage levels up to:
 not for fragrance use.
 
Recommendation for choline dihydrogen citrate flavor usage levels up to:
 not for flavor use.
 
Safety References:
EPI System: View
ClinicalTrials.gov:search
AIDS Citations:Search
Cancer Citations:Search
Toxicology Citations:Search
EPA Substance Registry Services (TSCA):77-91-8
EPA ACToR:Toxicology Data
EPA Substance Registry Services (SRS):Registry
Laboratory Chemical Safety Summary :66170
National Institute of Allergy and Infectious Diseases:Data
WGK Germany:2
2-(carboxymethyl)-2,4-dihydroxy-4-oxobutanoate;2-hydroxyethyl(trimethyl)azanium
Chemidplus:0000077918
RTECS:GA2582000 for cas# 77-91-8
 
References:
 2-(carboxymethyl)-2,4-dihydroxy-4-oxobutanoate;2-hydroxyethyl(trimethyl)azanium
NIST Chemistry WebBook:Search Inchi
Pubchem (cid):66170
Pubchem (sid):135023860
 
Other Information:
(IUPAC):Atomic Weights of the Elements 2011 (pdf)
Videos:The Periodic Table of Videos
tgsc:Atomic Weights use for this web site
(IUPAC):Periodic Table of the Elements
KEGG (GenomeNet):D07691
HMDB (The Human Metabolome Database):Search
Export Tariff Code:2923.10.0000
ChemSpider:View
Wikipedia:View
 
Potential Blenders and core components note
None Found
 
Potential Uses:
None Found
 
Occurrence (nature, food, other):note
 not found in nature
 
Synonyms:
2-(carboxymethyl)-2,4-dihydroxy-4-oxobutanoate; 2-hydroxyethyl-trimethylazanium
2-(carboxymethyl)-2,4-dihydroxy-4-oxobutanoate;2-hydroxyethyl(trimethyl)azanium
 cholex
 choline citrate (1:1) (salt)
 choline dihydrogen citrate conditioned
 choline dihydrogen citrate NF 12
 choline dihydrogen citrate NF 12 treated
 choline dihydrogencitrate salt
 choline, citrate (1:1) (salt)
 cholinedihydrogencitratesalt
 cholinvel
 chothyn
 cirrocolina
 citracholin
 citrocholine
 citrocol
 colicitrin
 delichol
 ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with 2-hydroxy-1,2,3-propanetricarboxylic acid
2-hydroxy-N,N,N-trimethylethanaminium 3-carboxy-2-(carboxymethyl)-2-hydroxypropanoate
2-hydroxy-N,N,N-trimethylethanaminium salt with 2-Hydroxy-1,2,3-propanetricarboxylic acid (1:1)
 neurotropan
 

Articles:

PubMed:Temporal B0 field variation effects on MRSI of the human prostate at 7 T and feasibility of correction using an internal field probe.
PubMed:Non-invasive estimation of prostate cancer aggressiveness using diffusion-weighted MRI and 3D proton MR spectroscopy at 3.0 T.
PubMed:Facilitating early recovery of bowel motility after colorectal surgery: a systematic review.
PubMed:Treatment of postoperative ileus with choline citrate--results of a prospective, randomised, placebo-controlled, double-blind multicentre trial.
PubMed:Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology.
PubMed:The effectiveness of choline citrate infusions monitored by lymphocyte transformation test (LTT) in multiple sclerosis. A new approach to the diagnosis and treatment of the disease.
PubMed:Adult prostate sarcoma: radiological-clinical correlation.
PubMed:Regarding the focal treatment of prostate cancer: inference of the Gleason grade from magnetic resonance spectroscopic imaging.
PubMed:Application of the inverse Monte Carlo treatment planning system IKO for an inhomogeneous dose prescription in the sense of dose painting.
PubMed:Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
PubMed:A proton NMR study of the effect of a new intravasal injectable male contraceptive RISUG on seminal plasma metabolites.
PubMed:The effects of choline supplementation on physical performance.
PubMed:Quantification by magnetic resonance spectroscopy of metabolites in seminal plasma able to differentiate different forms of azoospermia.
PubMed:Methionine, choline and sulfate interrelationships in the diet of weanling swine.
PubMed:Bioavailability of iron from ferric choline citrate and a ferric copper cobalt choline citrate complex for young pigs.
PubMed:Effect of small intestinal bypass on hepatic lipid accumulation in rats.
PubMed:Chemosensory responses by the heterotrophic marine dinoflagellateCrypthecodinium cohnii.
PubMed:Use of ferric choline citrate in the prevention of iron-deficiency anemia in baby pigs.
PubMed:Hemoglobin synthesis with iron choline citrate in hypochromic anemia of pregnancy.
PubMed:Effect of injected choline citrate in experimental atherosclerosis.
PubMed:[Effect of citrate and choline citrate on anaerobic synthesis of acetylcholine].
PubMed:[The effect of choline citrate on the carbohydrate metabolism].
PubMed:[Results with choline citrate therapy of inoperable cervical carcinoma].
PubMed:NEW and nonofficial remedies: choline dihydrogen citrate.
PubMed:[Choline citrate].
 
Notes:
None found
Please share your Comments.
Email Address:
Top of Page Home
Copyright © 1980-2021 The Good Scents Company (tgsc) ™ Disclaimer Privacy Policy